Skip to main content

Hisham Hamadeh

Vice President
Global Head of Data Science
Authored Items
Genmab Is Developing a World-Class Antibody Portfolio with the Hope to Bring the Right Cancer Therapy for the Right Patient
Kate Sasser, Hisham Hamadeh
Videos in Interview with the Innovators
Last modified: July 8, 2022